XNCR PEER ANALYSIS

Xencor Inc — metric-by-metric comparison with peers and the industry median

XNCRXencor Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

XNCRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	XNCR	MSB	TLX	CSL	RTALB	Ind. Median
P/E	—	—	—	29.96	4.78●	18.06
P/B	2.29	—	6.38	2.24	0.59●	3.62
EV/EBITDA	—	—	120.20	10.35●	72.98	15.13
P/S	12.11	31.30	3.24	2.66●	6.52	10.65

Financial Health
Metric	XNCR	MSB	TLX	CSL	RTALB	Ind. Median
Current Ratio	6.57●	—	1.43	2.57	1.21	5.90
Debt/Equity	34.0%	—	112.3%	67.4%	1.2%●	10.9%
NetDebt/EBITDA	2.05	—	13.13	2.22	0.90●	1.15

Profitability
Metric	XNCR	MSB	TLX	CSL	RTALB	Ind. Median
Net Margin	-177.1%	-115.3%	-0.9%	9.2%	136.3%●	-125.7%
ROE	-29.8%	-11.3%	-1.8%	7.7%	15.1%●	-47.5%
ROA	-21.0%	-8.6%	-0.7%	3.8%	13.1%●	-35.8%
EBITDA Margin	-135.2%	-76.6%	3.0%	32.8%●	9.0%	-105.8%

Growth + Dividend
Metric	XNCR	MSB	TLX	CSL	RTALB	Ind. Median
Rev. Growth	-29.2%	410.4%●	56.3%	4.8%	24.0%	5.1%
NI Growth	—	—	—	-39.4%	134.0%●	12.1%
Div. Yield	—	0.0%	—	2.5%●	0.0%	0.2%
Payout	—	0.0%	—	103.1%	0.0%	0.0%

Valuation
Metric	XNCR	MGTX	SANA	REPL	ANNX	EYPT	Ind. Median
P/E	—	—	—	—	—	—	18.06
P/B	2.29	-20.50●	9.57	6.39	6.11	5.23	3.62
EV/EBITDA	—	—	—	—	—	—	15.13
P/S	12.11●	14.94	—	—	—	158.33	10.65

Financial Health
Metric	XNCR	MGTX	SANA	REPL	ANNX	EYPT	Ind. Median
Current Ratio	6.57	0.55	1.29	4.79	6.35	6.66●	5.90
Debt/Equity	34.0%	-150.6%●	63.2%	17.0%	12.4%	8.8%	10.9%
NetDebt/EBITDA	2.05	-0.17●	0.14	0.77	1.03	0.78	1.15

Profitability
Metric	XNCR	MGTX	SANA	REPL	ANNX	EYPT	Ind. Median
Net Margin	-177.1%	-151.1%●	—	—	—	-3,566.6%	-125.7%
ROE	-29.8%●	—	-147.4%	-107.9%	-87.6%	-102.7%	-47.5%
ROA	-21.0%●	-51.4%	-59.1%	-71.0%	-69.4%	-83.5%	-35.8%
EBITDA Margin	-135.2%	-120.0%●	—	—	—	-3,415.1%	-105.8%

Growth + Dividend
Metric	XNCR	MGTX	SANA	REPL	ANNX	EYPT	Ind. Median
Rev. Growth	-29.2%	131.1%●	-100.0%	-100.0%	-100.0%	-86.4%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	0.1%	—	0.2%
Payout	—	—	—	—	-0.9%	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on XNCR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.